Tenax Therapeutics
Biotechnology ResearchNorth Carolina, United States11-50 Employees
Tenax Therapeutics is a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies.
Insights
Innovative Therapeutics Tenax Therapeutics is focused on developing novel cardiopulmonary therapies, indicating an opportunity to collaborate on cutting-edge treatment solutions within the biotech and pharmaceutical sectors.
Strong Financial Support The company has secured significant private placements totaling up to $125 million, demonstrating robust investor confidence and providing a solid financial foundation for upcoming product development and commercialization efforts.
Strategic Partnerships Partnership with RTW Investments highlights Tenax's openness to strategic alliances, presenting an opportunity to expand collaborations with investment firms and healthcare organizations seeking innovative therapeutics.
Growth and Expansion Recent participation in biotech conferences and leadership hires signify active growth initiatives and a focus on building leadership capacity, which could open avenues for sales in clinical research tools, services, or strategic advisory.
Technology Integration Utilization of diverse tech platforms like Google Cloud and Microsoft indicates advanced technological infrastructure, suggesting potential for digital health solutions, data management, and cloud-based service partnerships.
Similar companies to Tenax Therapeutics
Vapotherm
$25M$50MCohero Health
$1M$10MTandem Diabetes Care
$500M$1BInspire Medical Systems, Inc.
$250M$500MMasimo
$1B$10BSientra, Inc.
$10M$25MTetraphase Pharmaceuticals
$1M$10MSempre Health
$10M$25M
Tenax Therapeutics Tech Stack
Tenax Therapeutics uses 8 technology products and services including Google Cloud, Microsoft, Webflow, and more. Explore Tenax Therapeutics's tech stack below.
- Google CloudInfrastructure As A Service
- MicrosoftMiscellaneous
- WebflowPage Builders
- LuaProgramming Languages
- Yoast SEOSearch Engines
- BootstrapUI Frameworks
- ApacheWeb Servers
- OpenRestyWeb Servers
Media & News
Tenax Therapeutics's Email Address Formats
Tenax Therapeutics uses at least 1 format(s):
| Tenax Therapeutics Email Formats | Percentage |
| F.Last@tenaxthera.com | 50% |
| F.Last@tenaxthera.com | 50% |
Frequently Asked Questions
Where is Tenax Therapeutics's headquarters located?
Tenax Therapeutics's main headquarters is located at 101 Glen Lennox Drive, Suite 300. The company has employees across 1 continents, including North America. What is Tenax Therapeutics's phone number?
You can contact Tenax Therapeutics's main corporate office by phone at +1-919-855-****
What is Tenax Therapeutics's stock symbol?
Tenax Therapeutics is a publicly traded company; the company's stock symbol is TENX. What is Tenax Therapeutics's official website and social media links?
Tenax Therapeutics's official website is tenaxthera.com and has social profiles on LinkedInCrunchbase.What is Tenax Therapeutics's SIC code NAICS code?
Tenax Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Tenax Therapeutics have currently?
As of December 2025, Tenax Therapeutics has approximately 16 employees across 1 continents, including North America. Key team members include Chief Executive Officer: C. G.Chief Executive Officer: T. D.Chief Financial Officer: S. S.. Explore Tenax Therapeutics's employee directory with LeadIQ.What industry does Tenax Therapeutics belong to?
Tenax Therapeutics operates in the Biotechnology Research industry. What technology does Tenax Therapeutics use?
Tenax Therapeutics's tech stack includes Google CloudMicrosoftWebflowLuaYoast SEOBootstrapApacheOpenResty. What is Tenax Therapeutics's email format?
Tenax Therapeutics's email format typically follows the pattern of F.Last@tenaxthera.com. Find more Tenax Therapeutics email formats with LeadIQ. How much funding has Tenax Therapeutics raised to date?
As of December 2025, Tenax Therapeutics has raised $25M in funding. The last funding round occurred on Mar 05, 2025 for $25M.
Company Overview
- Headquarters
- 101 Glen Lennox Drive, Suite 300
- Phone number
- +1-919-855-****
- Website
- tenaxthera.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- TENX
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Employees
- 11-50
Media & News
Funding & Financials
- $25M
Tenax Therapeutics has raised a total of $25M of funding over 11 rounds. Their latest funding round was raised on Mar 05, 2025 in the amount of $25M.
- $1M$10M
Tenax Therapeutics's revenue is estimated to be in the range of $1M$10M
Funding & Financials
- $25M
Tenax Therapeutics has raised a total of $25M of funding over 11 rounds. Their latest funding round was raised on Mar 05, 2025 in the amount of $25M.
- $1M$10M
Tenax Therapeutics's revenue is estimated to be in the range of $1M$10M
Company Leadership
C. G.Chief Executive Officer- T. D.Chief Executive Officer
S. S.Chief Financial Officer- G. A.Vice President Clinical Operations
- T. M.Interim Chief Financial Officer
Employee Directory
- G. A.Vice President Clinical Operations
D. R.Evp, Business Development And Operations- D. B. H.Evp, Regulatory Affairs
- D. B. H.SVP, Regulatory Affairs
- C. L.Associate Director Clinical Operations
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
